Dual Roles for Endothelin-B Receptors in Modulating Adjuvant-Induced Inflammatory Hyperalgesia in Rats

Area of Science:

• Pharmacology
• Neuroscience
• Pain Research

Background:

• Endothelin-1 (ET-1) is implicated in pain signaling, acting via ET(A) and ET(B) receptors.
• ET-1 exhibits concentration-dependent effects on pain and tactile sensitization.
• The specific roles of ET receptors in inflammatory pain remain to be fully elucidated.

Purpose of the Study:

• To investigate the distinct roles of endothelin (ET) receptors in acute inflammatory hyperalgesia induced by complete Freund's adjuvant (CFA).
• To differentiate the contributions of ET(A) and ET(B) receptors to CFA-induced thermal hyperalgesia and allodynia.

Main Methods:

• Rats received injections of selective ET(A) and ET(B) receptor antagonists (BQ-123 and BQ-788, respectively) or an ET(B) receptor agonist (IRL-1620) before and during CFA administration.
• Thermal hyperalgesia and allodynia were assessed as measures of pain response.
• The effects of IRL-1620 were further examined in combination with antagonists and opioid-related agents.

Main Results:

• Both ET(A) and ET(B) receptor antagonists significantly reduced CFA-induced thermal hyperalgesia.
• Antagonists delayed the onset of allodynia but had minimal impact on its maximum intensity.
• The ET(B) receptor agonist IRL-1620 reduced thermal hyperalgesia and allodynia, an effect reversed by antagonists and opioid-related agents, suggesting activation of an endogenous analgesic pathway.

Conclusions:

• Endogenous ET-1 is crucial in mediating acute inflammatory pain.
• ET(B) receptors possess a dual function in inflammatory pain: promoting pain and activating local analgesic pathways.
• Distinct ET(B) receptor subtypes likely modulate inflammatory pain through complex interactions.